Ogawan, Victoria S.
HRN: 18-43-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2023
CO-AMOXICLAV 625MG (TAB)
08/02/2023
08/10/2023
PO
625mg
BID
7 Days
Waiting Final Action
08/02/2023
CEFTRIAXONE 1G (VIAL)
08/02/2023
08/08/2023
IV
2gms
OD
CAP MR
Waiting Final Action